Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemp-Derived Cannabinoids for Menopause Symptoms
NCT07393672Phase 2Recruiting
- Sponsor
- Washington State University
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in menopause and perimenopause (2 arms), sponsored by Washington State University. Primary endpoints: Center for Epidemiologic Studies Depression Scale at 13 weeks, Beck Anxiety Inventory at 13 weeks and 2 more. Started Feb 2026; status: recruiting.
02
Conditions
menopauseperimenopause
Beyond the preview
Go deeper on NCT07393672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393672.